PTPN3 Acts As a Tumor Suppressor and Boosts TGF-β Signaling Independent of Its Phosphatase Activity.
Bo Yuan,Jinquan Liu,Jin Cao,Yi Yu,Hanchenxi Zhang,Fei Wang,Yezhang Zhu,Mu Xiao,Sisi Liu,Youqiong Ye,Le Ma,Dewei Xu,Ningyi Xu,Yi Li,Bin Zhao,Pinglong Xu,Jianping Jin,Jianming Xu,Xi Chen,Li Shen,Xia Lin,Xin-Hua Feng
DOI: https://doi.org/10.15252/embj.201899945
2019-01-01
Abstract:TGF-β controls a variety of cellular functions during development. Abnormal TGF-β responses are commonly found in human diseases such as cancer, suggesting that TGF-β signaling must be tightly regulated. Here, we report that protein tyrosine phosphatase non-receptor 3 (PTPN3) profoundly potentiates TGF-β signaling independent of its phosphatase activity. PTPN3 stabilizes TGF-β type I receptor (TβRI) through attenuating the interaction between Smurf2 and TβRI Consequently, PTPN3 facilitates TGF-β-induced R-Smad phosphorylation, transcriptional responses, and subsequent physiological responses. Importantly, the leucine-to-arginine substitution at amino acid residue 232 (L232R) of PTPN3, a frequent mutation found in intrahepatic cholangiocarcinoma (ICC), disables its role in enhancing TGF-β signaling and abolishes its tumor-suppressive function. Our findings have revealed a vital role of PTPN3 in regulating TGF-β signaling during normal physiology and pathogenesis.